Pharmacological Treatment of Ankylosing Spondylitis A Systematic Review
作者： Pauline Boulos , Maxime Dougados , Stuart M MacLeod , Elke Hunsche
DOI: 10.2165/00003495-200565150-00004
关键词: Chemotherapy 、 Ankylosing spondylitis 、 Pharmacology toxicology 、 Pharmacotherapy 、 Pharmacological treatment 、 Medicine 、 Intensive care medicine 、 Physical therapy
摘要: The purpose of this study was to review the evidence regarding efficacy and safety pharmacological therapies currently available for treatment ankylosing spondylitis (AS).
springer.com
sci-hub.se 参考文章(97)
Webley M, Palferman Tg, A comparative study of nabumetone and indomethacin in ankylosing spondylitis. European journal of rheumatology and inflammation. ,vol. 11, pp. 23- 29 ,(1991)
W H Koh, A Samuels, S D Jones, I Pande, A Calin, Low dose amitriptyline in ankylosing spondylitis : A short term, double blind, placebo controlled study The Journal of Rheumatology. ,vol. 24, pp. 2158- 2161 ,(1997)
M Figueroa, A Raber, E Batlle-Gualda, J Ivorra, The efficacy and tolerability of aceclofenac in the treatment of patients with ankylosing spondylitis: a multicenter controlled clinical trial. Aceclofenac Indomethacin Study Group. The Journal of Rheumatology. ,vol. 23, pp. 1200- 1206 ,(1996)
Muhammad Asim Khan, A double blind comparison of diclofenac and indomethacin in the treatment of ankylosing spondylitis. The Journal of Rheumatology. ,vol. 14, pp. 118- 123 ,(1987)
K. Hovancik, M. D. Francis, R. W. Boyce, NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis. International Journal of Tissue Reactions-experimental and Clinical Aspects. ,vol. 11, pp. 239- 252 ,(1989)
D W Templin, G S Boyer, A P Lanier, Prevalence rates of spondyloarthropathies, rheumatoid arthritis, and other rheumatic disorders in an Alaskan Inupiat Eskimo population. The Journal of Rheumatology. ,vol. 15, pp. 678- 683 ,(1988)
H Whitelock, P Mallorie, A Calin, S Garrett, L G Kennedy, J O'Hea, T Jenkinson, A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. The Journal of Rheumatology. ,vol. 21, pp. 2281- 2285 ,(1994)
M Dougados, C Miceli-Richard, NSAIDs in ankylosing spondylitis. Clinical and Experimental Rheumatology. ,vol. 20, pp. 65- 66 ,(2002)
C H Goldsmith, E Atra, P Tugwell, M B Ferraz, Meta-analysis of sulfasalazine in ankylosing spondylitis. The Journal of Rheumatology. ,vol. 17, pp. 1482- 1486 ,(1990)
M Kurtinecz, J Bruckel, R D Inman, M A Stone, R W Warren, Progressive disability and functional impairment in females and males with ankylosing spondylitis is predicted by longer disease duration Arthritis & Rheumatism. ,vol. 48, ,(2003)